These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22797919)

  • 21. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
    Li H; Chen C
    Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
    Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
    Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
    Sliva D; Rizzo MT; English D
    J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
    Nalbandian A; Djakiew D
    Clin Exp Metastasis; 2006; 23(2):107-16. PubMed ID: 16912916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.
    Yang Y; Song S; Li S; Kang J; Li Y; Zhao N; Ye D; Qin F; Du Y; Sun J; Yu T; Wu H
    Cell Death Dis; 2024 Apr; 15(4):289. PubMed ID: 38653973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin inhibits highly invasive prostate cancer cells.
    Lloyd FP; Slivova V; Valachovicova T; Sliva D
    Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
    Chou RH; Hsieh SC; Yu YL; Huang MH; Huang YC; Hsieh YH
    PLoS One; 2013; 8(8):e71983. PubMed ID: 23940799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A distinct role of neutrophil lactoferrin in RelA/p65 phosphorylation on Ser536 by recruiting TNF receptor-associated factors to IkappaB kinase signaling complex.
    Oh SM; Lee SH; Lee BJ; Pyo CW; Yoo NK; Lee SY; Kim J; Choi SY
    J Immunol; 2007 Nov; 179(9):5686-92. PubMed ID: 17947640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thr435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation.
    O'Shea JM; Perkins ND
    Biochem J; 2010 Feb; 426(3):345-54. PubMed ID: 20001970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).
    Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J
    Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis.
    Ding X; Xu J; Wang C; Feng Q; Wang Q; Yang Y; Lu H; Wang F; Zhu K; Li W; Yan Q; Gao SJ; Lu C
    Cell Death Differ; 2019 Oct; 26(10):1970-1986. PubMed ID: 30670829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
    Joo JH; Jetten AM
    J Biol Chem; 2008 Jun; 283(24):16391-9. PubMed ID: 18424438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2-Dependent Manner.
    Roy A; Prasad S; Chen Y; Chao Y; Liu Y; Zhao J; Wang QJ
    Am J Pathol; 2023 May; 193(5):624-637. PubMed ID: 36740185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
    J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.